Consultants  /  Dr. Mohit Saxena
Haemato Oncology, Medical Oncology, Oncology consultant profile

Dr. Mohit Saxena

Consultant

Dharamshila Narayana Superspeciality Hospital →

Haemato Oncology, Medical Oncology, OncologyChemotherapy {Intravenousintrathecalintraperitoneal (HIPEC)
Professional overview

About Dr. Mohit Saxena

  • Dr. Mohit Saxena after completing his MBBS and MD – General medicine from Sawai Man Singh Medical college and hospital, Jaipur, Rajasthan, thereafter he has been extensively trained in the management of cancer patients at the Prestigious “Gujarat Cancer and Research Institute (GCRI), Ahmedabad” where he did his DM (Medical Oncology) and worked as senior resident (Medical Oncology) before moving to Delhi-NCR.
  • He worked as consultant, Medical Oncology in Artemis hospital, Gurgaon, Haryana for two and half years. He has vast experience in managing solid tumours and hematological malignancies. He has also worked VPS Rockland hospital, Qutub and Manesar; Paras hospital, Gurgaon and C.K. Birla hospital, Gurgaon and expanded his experience. His last organization was Fortis Flt. Lt. Rajan Dhall hospital, Vasant Kunj, New Delhi where he worked as empaneled consultant.
  • Currently he is working as Consultant, Medical Oncology and Hematology in Narayana Super Speciality Hospital, Gurgaon.
Clinical focus

Areas of expertise

  • Chemotherapy {Intravenous, intrathecal, intraperitoneal (HIPEC), Oral metronomic therapy}
  • Targeted therapy and precision medicine
  • Immunotherapy
  • Hormone therapy
Training and experience

Qualifications

  • MBBS – Sawai Man Singh Medical Colloege & Hospital, Jaipur, Rajasthan
  • MD (General medicine) – Sawai Man Singh Medical Colloege & Hospital, Jaipur, Rajasthan
  • DM (Medical Oncology) – Gujarat Cancer & Research Institute, Ahmedabad, Gujarat
Recognition

Awards

  • Faculty in “Oncology, Laser and Eye” in March 2020
  • Participation in “1st Mid year Uro-Oncology update” in August 2019
  • Faculty in the “Management of Cancer Thyroid : Paradigms & Challenges” in 2018
  • Participation in “Innovations in Oncology- Lung cancer edition” in April 2017
  • Participation in “20th National CMI in haematology” in Jan.-Feb. 2015
  • Participation in zonal round of Torrent Young Scholar Award (TYSA) programme in Dec. 2014
  • Training of Good Clinical Practice Workshop in Dec. 2012
  • Merit (9th) in 12TH Board of Secondary Education, Rajasthan in year 1998
  • Professional Memberships & Certifications
  • American Society of Clinical Oncology (ASCO)
Research

Publications

  • Saxena M, Madabhavi I, Patel A et al. Experience of Sorafenib as First-Line Treatment in Metastatic Renal Cell Carcinoma in a Tertiary Care Centre. Int J Hematol Oncol Stem Cell Res 2018 Jul 1; 12(3): 197–203.
  • Saxena M, Panchal H P, Parikh S K et al. High dose Cytarabinearabinoside (Ara-C) as a culprit of leukoencephalopathyin a patient of acute myeloid leukemia. Vidarbha Journal of Internal Medicine 2015 July; 19: 63-66.
  • Saxena M, Rao RS, Sharma BB et al. Primary Anaemia (Haematological Causes): A Prevalence Study in A Tertiary Care Centre. Current Medical Trends 2008; 12:2318-24
Need help deciding?

Request coordinated guidance for your case.

Share your reports to understand suitable consultants, hospitals and next steps.

Request guidance →